Gastrointestinal side effects represent the primary concern with all incretin-based therapies
After more than a decade, Oprah Winfrey returned to prime-time TV last week for an ABC special titled Shame, Blame and the Weight Loss Revolution to share her public battle with weight and her decision to use new GLP-1 medications to help manage it
FDA approved MOUNJARO based on evidence from nine clinical trials of 7,769 patients with type 2 diabetes mellitus, of which 5,415 of these patients received MOUNJARO
and People Magazines year-end cover story about media celebrity Oprah Winfrey, People (December 25, 2023): Oprah Winfrey reveals she uses weight-loss medication as a maintenance tool: Im absolutely done with the shaming (exclusive) ( and 2 This invited perspective article has been part of the recent turns of events, with earlier drafts having circulated since September 2023 to colleagues as well as to journalists investigating Mojsovs role in the discovery of GLP-1
Amino acids: metabolism, functions, and nutrition